RevCycle Intelligence November 27, 2023
Victoria Bailey

The growth of Medicare Part D claims subject to 340B discounts was driven by increases in claims written by 340B-affiliated clinicians and prescribed by 340B pharmacies.

The share of Medicare Part D claims eligible for discounts in the 340B drug pricing program increased from 1.7 percent to 9.6 percent between 2013 and 2020, a study published in JAMA Health Forum indicated.

The 340B program allows certain healthcare entities to acquire outpatient prescription drugs at a discounted price. These entities often include disproportionate share hospitals, children’s hospitals, free-standing cancer hospitals, critical access hospitals, and federally qualified health centers.

Prescriptions must be written by a 340B-affiliated clinician and dispensed from an in-house or contract pharmacy to be eligible for 340B discounts.

Researchers...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Health System / Hospital, Insurance, Medicare, Provider, Survey / Study, Trends
Biden administration proposes Medicare coverage for weight loss drugs: 10 things to know
Proposed Coverage of Anti-Obesity Drugs in Medicare and Medicaid Would Expand Access to Millions of People with Obesity
Prior authorizations, pharmacy transparency, vertical integration all part of the Medicare 2026 rule
Medicare and Medicaid would cover Ozempic, Wegovy under new Biden rule
New Proposal Aims to Expand Medicaid and Medicare Coverage for Obesity Drugs

Share This Article